These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8565996

  • 1. Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disks.
    Barry AL, Brown SD, Novick WJ.
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):724-6. PubMed ID: 8565996
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.
    Barry AL, Fuchs PC.
    J Clin Microbiol; 1995 Apr; 33(4):1031-3. PubMed ID: 7790431
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG, Erwin ME, Jones RN.
    Diagn Microbiol Infect Dis; 1995 Apr; 22(1-2):119-23. PubMed ID: 7587024
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW, Aldridge KE, Gelfand MS.
    Diagn Microbiol Infect Dis; 1995 Apr; 22(1-2):35-42. PubMed ID: 7587048
    [Abstract] [Full Text] [Related]

  • 13. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
    Bell SM, Gatus BJ, Pham JN.
    Med J Aust; 1996 Feb 05; 164(3):188. PubMed ID: 8628145
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R, Navarro C, Egido P, Aspiroz C, Goñi P, Vergara Y, Garcia C, Duran E, Castillo J, Rubio MC.
    J Chemother; 2000 Feb 05; 12(1):17-21. PubMed ID: 10768511
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN, Barry AL, Thornsberry C.
    Diagn Microbiol Infect Dis; 1986 Apr 05; 4(4):345-9. PubMed ID: 3698547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci.
    Livermore DM, Warner M, Mushtaq S.
    Int J Antimicrob Agents; 2014 Feb 05; 43(2):131-4. PubMed ID: 24361355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.